Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 18543352)

Published in Pharmacoepidemiol Drug Saf on September 01, 2008

Authors

Carlos G Grijalva1, Cecilia P Chung, C Michael Stein, Patricia S Gideon, Shannon M Dyer, Edward F Mitchel, Marie R Griffin

Author Affiliations

1: Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37212, USA. carlos.grijalva@vanderbilt.edu

Articles citing this

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77

Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis (2011) 1.94

A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf (2012) 1.86

Validity of administrative data in recording sepsis: a systematic review. Crit Care (2015) 1.21

Initiation of rheumatoid arthritis treatments and the risk of serious infections. Rheumatology (Oxford) (2009) 1.10

Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011. Arthritis Care Res (Hoboken) (2015) 0.89

The health services burden of heart failure: an analysis using linked population health data-sets. BMC Health Serv Res (2012) 0.87

A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Arthritis Care Res (Hoboken) (2015) 0.85

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study. Ann Rheum Dis (2013) 0.84

National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia. PLoS One (2016) 0.81

Sepsis surveillance from administrative data in the absence of a perfect verification. Ann Epidemiol (2016) 0.80

Validation and optimisation of an ICD-10-coded case definition for sepsis using administrative health data. BMJ Open (2015) 0.78

Opioid Analgesics and the Risk of Serious Infections Among Patients With Rheumatoid Arthritis: A Self-Controlled Case Series Study. Arthritis Rheumatol (2016) 0.78

Low Completeness of Bacteraemia Registration in the Danish National Patient Registry. PLoS One (2015) 0.77

Articles cited by this

The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum (2004) 6.22

Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60

Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet (2006) 4.42

Validation of diagnostic codes within medical services claims. J Clin Epidemiol (2004) 4.37

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum (2006) 4.20

Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum (2007) 3.38

The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis (2004) 2.96

Veteran's affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol (2006) 2.51

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Arthritis Rheum (2007) 1.43

Data validity issues in using claims data. Pharmacoepidemiol Drug Saf (2002) 1.13

Use of predictive value to adjust relative risk estimates biased by misclassification of outcome status. Am J Epidemiol (1983) 1.10

Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here? Arthritis Rheum (2004) 1.04

Laboratory diagnosis of invasive mycoses. Infect Dis Clin North Am (2003) 0.83

Articles by these authors

The burden of respiratory syncytial virus infection in young children. N Engl J Med (2009) 8.95

The underrecognized burden of influenza in young children. N Engl J Med (2006) 8.25

Azithromycin and the risk of cardiovascular death. N Engl J Med (2012) 8.18

Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med (2009) 7.89

Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med (2008) 7.13

Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med (2006) 6.83

Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med (2004) 6.21

Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics (2004) 5.74

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet (2007) 5.50

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study. Lancet (2002) 5.17

Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA (2009) 4.61

Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 4.58

New drugs for rheumatoid arthritis. N Engl J Med (2004) 4.38

Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med (2005) 4.04

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02

Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med (2008) 3.84

Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis (2001) 3.73

Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med (2006) 3.72

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58

Rhinovirus-associated hospitalizations in young children. J Infect Dis (2007) 3.35

Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis (2004) 3.25

Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum (2005) 3.17

ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12

Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol (2006) 3.10

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA (2006) 2.93

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis (2012) 2.91

Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med (2010) 2.90

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Ann Intern Med (2010) 2.73

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2007) 2.60

A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol (2008) 2.53

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet (2002) 2.49

Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J (2013) 2.47

Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf (2008) 2.46

Accuracy and interpretation of rapid influenza tests in children. Pediatrics (2007) 2.43

Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics (2008) 2.29

Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy. Pediatrics (2007) 2.20

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med (2012) 2.18

Reform of drug regulation--beyond an independent drug-safety board. N Engl J Med (2006) 2.17

Blacks have a greater sensitivity to α1-adrenoceptor-mediated venoconstriction compared with whites. Hypertension (2013) 2.13

Influenza burden for children with asthma. Pediatrics (2008) 2.10

Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol (2003) 2.09

Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis (2010) 2.09

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics (2006) 2.01

High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis (2006) 2.00

Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Blood (2008) 1.99

A computer case definition for sudden cardiac death. Pharmacoepidemiol Drug Saf (2010) 1.97

Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry (2013) 1.95

Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls. Pediatr Infect Dis J (2012) 1.93

Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis (2011) 1.93

ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol (2010) 1.92

Comparative effectiveness of incident oral antidiabetic drugs on kidney function. Kidney Int (2012) 1.92

The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol (2009) 1.91

Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes (2009) 1.90

Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr (2009) 1.90

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab (2014) 1.88

CYP2C9 allelic variants: ethnic distribution and functional significance. Adv Drug Deliv Rev (2002) 1.86

ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Circulation (2010) 1.86

The aprotinin story--is BART the final chapter? N Engl J Med (2008) 1.84

Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2004) 1.84

Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis (2012) 1.84

Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics (2013) 1.83

Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Gastroenterology (2007) 1.80

Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis (2008) 1.80

Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum (2005) 1.80

Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease. Arch Intern Med (2007) 1.78

Failure of routine diagnostic methods to detect influenza in hospitalized older adults. Infect Control Hosp Epidemiol (2010) 1.77

Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Blood (2011) 1.77

Trends in antibiotic prescribing for adults in the United States--1995 to 2002. J Gen Intern Med (2005) 1.75

Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) 1.73

Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol (2002) 1.70

The burden of influenza in young children, 2004-2009. Pediatrics (2013) 1.68

Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med (2005) 1.68

Emergence of parapneumonic empyema in the USA. Thorax (2011) 1.67

Burden of human metapneumovirus infection in young children. N Engl J Med (2013) 1.65

Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease. Epidemiology (2010) 1.63

Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum (2008) 1.63

Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans. J Infect Dis (2009) 1.63

Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Med Care (2007) 1.62

Medical care utilization and mortality in sickle cell disease: a population-based study. Am J Hematol (2005) 1.61

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics (2007) 1.61

Changes in antibiotic prescribing for children after a community-wide campaign. JAMA (2002) 1.59

Resident work hour limits and patient safety. Ann Surg (2005) 1.58